Markers of systemic inflammation correlate with survival prognosis in patients with newly diagnosed brain metastases

Background null Cancer - immune system interactions are currently in focus of oncology research as immune modulating therapies have shown remarkable activity, also in patients with brain metastases (BM). Therefore, we aimed to investigate markers of systemic inflammation and their impact on survival prognosis in a large real-life cohort of BM patients. null null null Methods null 1250 patients with newly diagnosed BM were identified from the...